Information Journal Paper
APA:
Copy. (2017). Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH, 36(-), 107-120. SID. https://sid.ir/paper/724064/en
Vancouver:
Copy. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH[Internet]. 2017;36(-):107-120. Available from: https://sid.ir/paper/724064/en
IEEE:
Copy, “Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2),” JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH, vol. 36, no. -, pp. 107–120, 2017, [Online]. Available: https://sid.ir/paper/724064/en